Mds Podcast
Perampanel may reduce alpha-synuclein transmission in Parkinson's disease. A possible therapeutic target?Â
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:14:26
- Mas informaciones
Informações:
Sinopsis
Dr. Matarazzo speaks with Prof. Takahashi about the results of his recent study that shows how this anti-epileptic drug may inhibit the transmission of alpha synuclein in PD. While this was tested in animal models, future clinical trials are warranted to test the effects on PD progression.
